EEG seizure activity and behavioral neurotoxicity produced by (+)-MK801, but not the glycine site antagonist L-687,414, in the rat

Neuropharmacology

Volumn 35, Issue 4, 1996, Pages 441-448

  Tortella, F C ^a   Hill, R G ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

(+) HA966; (+) MK801; behavioral neurotoxicity; EEG seizures; glycine; L 687,414; N methyl D aspartate (NMDA)

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 3 AMINO 1 HYDROXY 4 METHYL 2 PYRROLIDINONE; ANTICONVULSIVE AGENT; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ELECTROENCEPHALOGRAM; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0029942928     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00190-5     Document Type: Article

References (24)

1. Bonta I. L., De Vos C. J., Grijsen H., Hillen F. C., Noach E. L. and Sim A. W. (1971) 1-Hydroxy-3-amino-pyrrolidone-2 (HA966): a new GABA-like compound, with potential use in extrapyramidal diseases. Br. J. Pharmacol. 43: 514-535.
2. Buchan A. M. (1990) Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? Cereb. Brain Metab. Rev. 2: 1-26.
3. Choi D. W. (1993) NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation. Prog. Brain Res. 96: 137-143.
4. Contreras P. C. (1990) D-Serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29: 291-293.
5. Dave J. R. and Tortella F. C. (1992) PD117302, an opioid kappa agonist, and MK801 partially block maximal electroshock convulsion-induced increases in c-fos mRNA in rat brain. Pharmacol. Comm. 1: 319-328.
6. Foster A. C., Kemp J. A., Tricklebank M. D., Leeson P. D., Carling R. W., Williams B. J., Grimwood S., Donald A. E., Priestly T., Marshall G. R., Saywell K. and Gill R. (1992) Selective antagonists for the glycine site of the N-methyl-D-aspartate receptor. Molec. Pharmacol. 2: 97-102.
7. Gill R., Hargreaves R. J. and Kemp J. A. (1995) The neuroprotective effect of the glycine site antagonist 3R-(+)-cis-4-methyl-HA966 (L-687,414) in a rat model of focal ischemia. J. Cereb. Blood Flow Metab. 15: 197-204.
8. Hargreaves R. J., Rigby M., Smith D. and Hill R. G. (1993) Lack of effect of L-687,414 [(+)-cis-4-methyl-HA-966], an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br. J. Pharmacol. 110: 36-42.
9. Iversen L., Foster A. C., Hill R. G., Iverson S. D., Kemp J. A., Leeson P. D., Rupniak N. M., Saywell K., Tricklebank M. D. and Williams B. J. (1992) Neurotoxin-related research: From the laboratory to the clinic. Ann. N.Y.Acad. Sci. 648: 207-218.
10. Kemp J. A. and Leeson P. D. (1993) The glycine site of the NMDA receptor - five years on. Trends Pharmacol. Sci. 14: 20-25.
11. Khazan N. (1975) The implication and significance of EEG and sleep-awake activity in the study of experimental drug dependence on morphine. In: Methods in Narcotic Research (Ehrenpreis S. and Neidle A., eds), pp. 173-215. Marcel Dekker, New York.
12. Kurumaji A. and McCulloch J. (1989) Effects of MK-801 upon local cerebral glucose utilization in conscious rats and in rats anesthetized with halothane. J. Cereb. Blood Flow Metab. 9: 786-794.
13. Leeson P. D., Williams B. J., Baker R., Ladduwahety T., Moore K. W. and Rowley M. (1990) Effects of five-membered ring conformation on bioreceptor recognition: Identification of 3R-amino-1-hydroxy-4R-methylpyrrolidin-2-one (L-687,414) as a potent glycine/N-methyl-D-aspartate receptor antagonist. J. Chem. Soc. Chem. Commun.: 1578-1580.
14. Leeson P. D. and Iversen L. L. (1994) The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential. J. med. Chem. 37: 4053-4067.
15. McCulloch J. and Iversen L. L. (1991) Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo. Neurochem. Res. 16: 951-963.
16. Nehls D. G., Park C. K., MacCormack A. G. and McCulloch J. (1990) The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilization. Brain Res. 511: 271-279.
17. Olney J. W., Labruyere J. and Price M. T. (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1515-1518.
18. Rogawski M. A. (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14: 325-331.
19. Saywell K., Singh L., Oles R. J., Vass C., Leeson P. D., Williams B. J. and Tricklebank M. D. (1991) The anticonvulsant properties in the mouse of the glycine/NMDA receptor antagonist L-687,414. Br. J. Pharmacol. 102: 66P.
20. Singh L., Donald A. E., Foster A. C., Hutson P. H., Iversen L. L., Iversen S. D., Kemp J. A., Leeson P. D., Marshall G. R., Oles R. J., Priestly T., Thorn L., Tricklebank M. D., Vass C. A. and Williams B. J. (1990) Enantiomers of HA-966 (3-amino-1-hydroxypyrrolidin-2-one) exhibit distinct central nervous system effects: (+)HA-966is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)HA-966 is a potent butyrolactone-like sedative. Proc. natn. Acad. Sci. U.S.A. 87: 347-351.
21. Smith S. E. and Meldrum B. S. (1992) The glycine site NMDA receptor antagonist, A-(+)-cis-β-methyl-3-amino-1-hydroxy-pyrrolid-2-one, L-687,414 is anticonvulsant in baboons. Eur. J. Pharmacol. 211: 109-111.
22. Tallarida R. J. and Murray R. B. (1987) Procedure #46. In: Manual of Pharmacologic Calculations with Computer Programs, pp. 153-159. Springer-Verlag, New York.
23. Tortella F. C., Robles L. and Holaday J. W. (1986) U50,488, a highly selective kappa opioid: Anticonvulsant profile in rats. J. Pharmacol. Exp. Ther. 237: 49-53.
24. Tortella F. C. and Hill R. G. (1993) Electroencephalographic seizure activity produced by MK801 but not by the gly-site NMDA antagonist L-687,414. Neurosci. Abst. 19: 1697.